Evidence was shown glucagon to be one of the most potent lipolytic hormones active on adipose tissue in several species in vitro (LEFEBVRE and LUYCKX, 1969) .
Thus, glucagon-induced lipolysis should be expected to result in a rise in bloodfree fatty acid (FFA) concentration. In fact, an elevation of blood FFA level has been reported in various animals, including dog and man (FOA, 1968) . However, it should be recognized that the changes in blood FFA level due to glucagon have been found to be inconsistent; parenteral glucagon may cause an increase, a decrease, a diphasic or a triphasic change in blood FFA concentration. Such differences observed in the effects of glucagon have yielded conflicting interpretations about the mechanisms involved in in vivo effect of glucagon. Moreover, there has been no report of glucagon effect on blood FFA in rats, although a lipolytic action of glucagon has been shown mainly in rat adipose tissue in vitro (HAGEN, 1961; STEINBERG et al., 1959; VAUGHAN and STEINBERG, 1963; WEINIGES, 1961; WEINIGES and LOEFFLER, 1965) . The explanation for this fact might be in part found in a difficulty in succesive sampling of blood under non-stress conditions from such a small animal as rat. KUROSHIMA et al.(1975) have previously succeeded in obtaining blood samples from the locally anesthetized tail of rat under unanesthetized condition. Obviously, the significance of in vitro lipolytic action of glucagon would be enhanced if it were confirmed by in vivo studies. In this context, the present study was undertaken to reveal an in vivo lipolytic action of glucagon in rats and furthermore any change of sensitivity to its action in coldadapted animals. liter) 5min after the injection. On the other hand, a reelevation of blood FFA level at 240min was not provoked in the fasted cold-adapted rats. Both glucose and lactate levels did not show any significant changes after glucagon injection as compared with those in the vehicle control (Table 3) .
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DISCUSSION
To our knowledge, the present result clearly demonstrates an in vivo lipolytic action of glucagon in rats for the first time and confirms the in vitro results previously shown in rats (LEFEBVRE and LUYCKX, 1969) . The pattern of changes in blood FFA concentrations induced by glucagon in the present study is essentially the same as that previously reported in dogs by WHITTY et al.(1969) ; blood FFA level showed the triphasic changes after glucagon injection, an immediate rise at 5min, secondary depression and a final rise 3 to 4hr in the intact and depancreatized dogs. They discussed that the initial rise at 5min, which could not be prevented by the concurrent rise of glucose and insulin levels, might well result from a rapid stimulation of lipolysis by glucagon. And, although it is likely that catecholamines are contributed to the initial rise in blood FFA level, since these have been shown to be released within a few minutes after the injection of glucagon in men and rats (LE-FEBVRE et al., 1968) , this explanation would not be satisfactory, at least in their experiment, because catecholamines should have suppressed the blood insulin response (PoRTE et al., 1966) . Consequently, the initial rise of blood FFA at 5min in the dog would appear to be evoked by a direct action of glucagon on adipose tissue. WHITTY et al.(1969) also suggested that the secondary fall of FFA could be ascribed to glucagon-induced hyperglycemia and insulin release and a final rise in FFA might be simply the manifestation of a continuing lipolytic action of glucagon which had been temporarily halted or reversed by the sharp increase in serum glucose and insulin. However, it is rather difficult to believe that glucagon administered still exerts its lipolytic action 2 to 4hr after the injection. As mentioned above, mechanisms responsible for an in vivo increase of blood FFA after glucagon administration is complicated, possibly by various factors which could be elicited by glucagon. In consideration of the results by WHITTY et al.(1969) , the present result in rats showing that both blood FFA and glucose rose concurrently at 5min after glucagon may also indicate a primary in vivo lipolytic action of this hormone on adipose tissue. However, further study should be required to elucidate the mechanism (s) involved in the triphasic changes in blood FFA levels induced by glucagon in rats.
Recently, glucagon has been recognized as energy-yielding hormone in need of increased endogenous production of fuels, for example, in starvation (AGUILAR-PARADA et al., 1969) , in experimentally induced hypoglycemia (UNGER et al., 1962) and in exercise (BOETTIGER et al., 1972; FELIG et al., 1972) . In cold adaptation which has need for increased fuels an increased sensitivity to metabolic action of noradrenaline has been shown (HREH et al., 1957) . Therefore, it seemed to be interesting to study the effect of glucagon in the cold-adapted animals. The present study demonstrated that glucagon caused significantly greater increase of blood FFA concentration in the fasted cold-adapted rats than in the fasted warm-adapted ones at 5min after glucagon. It is well known that fasting results in an increased mobilization and utilization of fatty acids, accompanied by an elevated level of blood FFA. Accordingly, it could be concluded that a lipolytic action of glucagon is potentiated due to cold adaptation under the condition of enhanced FFA utilization as in the fast state. It is also conceivable that such a potentiated sensitivity to lipolytic action of glucagon might be contributable to an accelerated utilization of lipids in cold adaptation (MASORO, 1966) . So far, a role of endocrine function in metabolic adaptation to cold appears to have been investigated exclusively from the view point of the changes in endocrinal secretions, except on an increased sensitivity to metabolic action of norepinephrine. The present study apparently suggests that an increased sensitivity to metabolic action of hormonal factors other than norepinephrine would also be involved in the mechanism of cold adaptation.
On the contrary to an increased sensitivity to glucagon at 5min after glucagon in the fasted cold-adapted rats, it was noticed that an elevation of blood FFA at 240min was not found in these animals. The reason for this finding remained unexplained in the present study. According to the recent study by WEISER and GRANDE (1974) , glucagon caused an elevation of oxygen consumption and at the same time a decrease in plasma FFA concentration in dogs. They suggest that a calorigenic effect of this hormone is related to an increased utilization and oxidation of circulating FFA by the liver, resulting in a decreased plasma FFA level. Thus, an apparent suppression of glucagon-induced blood FFA elevation 240min after the injection of glucagon in cold-adapted rats might be due to a stimulated fatty acid oxidation as well as lipolysis developed by cold adaptation. However, such speculation should be verified by further study as to relation of the changes in blood FFA levels to those in energy metabolism.
